These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 29152580)

  • 1. Chromosomal Targeting by the Type III-A CRISPR-Cas System Can Reshape Genomes in
    Guan J; Wang W; Sun B
    mSphere; 2017; 2(6):. PubMed ID: 29152580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and functional study of type III-A CRISPR-Cas systems in clinical isolates of Staphylococcus aureus.
    Cao L; Gao CH; Zhu J; Zhao L; Wu Q; Li M; Sun B
    Int J Med Microbiol; 2016 Dec; 306(8):686-696. PubMed ID: 27600408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Endogenous Staphylococcus aureus CRISPR-Cas System Limits Phage Proliferation and Is Efficiently Excised from the Genome as Part of the SCC
    Mikkelsen K; Bowring JZ; Ng YK; Svanberg Frisinger F; Maglegaard JK; Li Q; Sieber RN; Petersen A; Andersen PS; Rostøl JT; Høyland-Kroghsbo NM; Ingmer H
    Microbiol Spectr; 2023 Aug; 11(4):e0127723. PubMed ID: 37404143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional Characterization of Type III-A CRISPR-Cas in a Clinical Human Methicillin-R
    Li Y; Mikkelsen K; Lluch I Grané O; Wang Z; Tang Y; Jiao X; Ingmer H; Høyland-Kroghsbo NM; Li Q
    CRISPR J; 2021 Oct; 4(5):686-698. PubMed ID: 34558981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CRISPR Spacer Space Is Dominated by Sequences from Species-Specific Mobilomes.
    Shmakov SA; Sitnik V; Makarova KS; Wolf YI; Severinov KV; Koonin EV
    mBio; 2017 Sep; 8(5):. PubMed ID: 28928211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of 67 Confirmed Clustered Regularly Interspaced Short Palindromic Repeats Loci in 52 Strains of
    Wang Y; Mao T; Li Y; Xiao W; Liang X; Duan G; Yang H
    Front Microbiol; 2021; 12():736565. PubMed ID: 34751223
    [No Abstract]   [Full Text] [Related]  

  • 7. Survey of clustered regularly interspaced short palindromic repeats and their associated Cas proteins (CRISPR/Cas) systems in multiple sequenced strains of Klebsiella pneumoniae.
    Ostria-Hernández ML; Sánchez-Vallejo CJ; Ibarra JA; Castro-Escarpulli G
    BMC Res Notes; 2015 Aug; 8():332. PubMed ID: 26238567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and Characterization of the CRISPR/Cas System in
    Cruz-López EA; Rivera G; Cruz-Hernández MA; Martínez-Vázquez AV; Castro-Escarpulli G; Flores-Magallón R; Vázquez K; Cruz-Pulido WL; Bocanegra-García V
    Front Microbiol; 2021; 12():656996. PubMed ID: 34149645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Different Target Sequences on Type III CRISPR-Cas Immunity.
    Maniv I; Jiang W; Bikard D; Marraffini LA
    J Bacteriol; 2016 Jan; 198(6):941-50. PubMed ID: 26755632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the features of 45 identified CRISPR loci in 32 Staphylococcus aureus.
    Yang S; Liu J; Shao F; Wang P; Duan G; Yang H
    Biochem Biophys Res Commun; 2015 Aug; 464(3):894-900. PubMed ID: 26188514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-cas spacers in orphan CRISPR4 arrays prevent uptake of active CRISPR-Cas I-F systems.
    Almendros C; Guzmán NM; García-Martínez J; Mojica FJ
    Nat Microbiol; 2016 Jun; 1(8):16081. PubMed ID: 27573106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR-Cas systems and RNA-guided interference.
    Barrangou R
    Wiley Interdiscip Rev RNA; 2013; 4(3):267-78. PubMed ID: 23520078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic characterization of antiplasmid immunity through a type III-A CRISPR-Cas system.
    Hatoum-Aslan A; Maniv I; Samai P; Marraffini LA
    J Bacteriol; 2014 Jan; 196(2):310-7. PubMed ID: 24187086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic chromosomal targeting by CRISPR/Cas systems can reshape bacterial genomes and expel or remodel pathogenicity islands.
    Vercoe RB; Chang JT; Dy RL; Taylor C; Gristwood T; Clulow JS; Richter C; Przybilski R; Pitman AR; Fineran PC
    PLoS Genet; 2013 Apr; 9(4):e1003454. PubMed ID: 23637624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three CRISPR-Cas immune effector complexes coexist in Pyrococcus furiosus.
    Majumdar S; Zhao P; Pfister NT; Compton M; Olson S; Glover CV; Wells L; Graveley BR; Terns RM; Terns MP
    RNA; 2015 Jun; 21(6):1147-58. PubMed ID: 25904135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-based screening of genomic island excision events in bacteria.
    Selle K; Klaenhammer TR; Barrangou R
    Proc Natl Acad Sci U S A; 2015 Jun; 112(26):8076-81. PubMed ID: 26080436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between type IIIA CRISPR-Cas system and SCCmec in Staphylococcus epidermidis.
    Zhu T; Zhao Y
    Arch Microbiol; 2021 Dec; 203(10):6275-6286. PubMed ID: 34668031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Friendly Fire: Biological Functions and Consequences of Chromosomal Targeting by CRISPR-Cas Systems.
    Heussler GE; O'Toole GA
    J Bacteriol; 2016 May; 198(10):1481-6. PubMed ID: 26929301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The subtype I-F CRISPR-Cas system influences pathogenicity island retention in Pectobacterium atrosepticum via crRNA generation and Csy complex formation.
    Richter C; Fineran PC
    Biochem Soc Trans; 2013 Dec; 41(6):1468-74. PubMed ID: 24256239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence and Diversity of CRISPR-Cas Systems in the Genus Bifidobacterium.
    Briner AE; Lugli GA; Milani C; Duranti S; Turroni F; Gueimonde M; Margolles A; van Sinderen D; Ventura M; Barrangou R
    PLoS One; 2015; 10(7):e0133661. PubMed ID: 26230606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.